IP Library Granted Patent US 6,846,645
Granted Patent B2
US 6,846,645 · App. 10/613,583 · Granted Jan 25, 2005

Multiplexed enzymatic assays

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,846,645
App. No.
10/613,583
Granted
Jan 25, 2005
Kind
B2
Abstract

A mutiplexed enzyme assay method and substrate set for performing the method are disclosed. The method includes performing a plurality of enzyme reactions in the presence of a plurality of enzymes substrates, under conditions effective to convert an enzyme substrate to a corresponding product, where the product of each substrate and the substrate have different separation characteristics from each other and from the other substrates and their corresponding products. After performing the reactions, which may be carried out in separate or combined reactions, the substrates and products in said reactions are separated in a single separation medium. For each separated product and substrate, a separation characteristic effective to identify that product and substrate and a signal related to the amount of the product and substrate is detected. From this, one can determine the amount of substrate converted to the corresponding product in each of the reactions.

Claims (14)

1. A method for simultaneously assaying the activities of multiple kinases in a cell-signaling pathway, the method comprising the steps of:

providing in a reaction mixture a set of kinase substrates under conditions effective to convert a kinase substrate in the set to a corresponding product in the presence of the kinase for that substrate, where (i) each kinase substrate and the product of that kinase substrate have different separation characteristics from each other and from the other kinase substrates in the set and their corresponding products and (ii) each kinase substrate and its corresponding product have a detection moiety capable of producing a detectable signal;

separating the kinase substrates and products in said reactions in a single separation medium;

detecting, for each separated product, a separation characteristic effective to identify that product and a signal related to the amount of the product; and

determining, from the detected separation characteristic and signal detected for each product, the amount of each kinase substrate converted to the corresponding product in said reaction mixture.

2. The method of claim 1 wherein said separation characteristic of said kinase substrates and said products is electrophoretic mobility, and said separating includes separating said kinase substrates and corresponding products within an electrophoretic medium under the influence of an applied electric field.

3. The method of claim 2 wherein said kinase substrates and corresponding products are separated by capillary electrophoresis.

4. The method of claim 1 wherein said detecting further includes detecting, for each of said kinase substrates, a separation characteristic effective to identify that kinase substrate and a signal related to the amount of the kinase substrate.

5. The method of claim 1 wherein said substrates and corresponding products are fluorescently labeled, and said detecting includes detecting the fluorescent signal from each product when irradiated with a fluorescence excitation wavelength.

6. The method of claim 1 for use in determining the levels of activity of each of a plurality of different kinases in a cell, under selected cell conditions, wherein said different kinases in said reaction mixture are obtained from said cell under such selected cell conditions.

7. The method of claim 6 for determining changes in the levels of activity of each of a group of kinases in a cell, in control and test cell conditions, wherein said steps of providing, separating, detecting, and determining are carried out for kinases obtained from the cells at the control and test conditions.

8. The method of claim 6 for determining changes in the levels of activity of each of a group of kinases in a cell, when the cell is exposed to an agent known or being tested for its ability to inhibit or activate the level of the activity of one or more of said different kinases, wherein said steps of providing, separating, detecting, and determining are carried out for kinases obtained from the cells before and after exposure to said agent.

9. The method according to claims 1 , 2 , 3 , 4 , 5 , 6 , 7 , or 8 wherein said multiple kinases include kinases selected from the group consisiting of ERK kinase, S6 kinase, P38 kinase, AbI kinase, cyclic nucleotide-regulated protein kinase, protein kinase C, kinase regulated by Ca2+/CaM, cyclin-dependent kinase, protein-tyrosine kinase, Src kinase, INK, MAP kinase, P53 kinase, platelet-derived growth factor receptor, epidermal growth factor receptor, and MEK.

10. The method of claim 9 wherein said multiple kinases include kinases selected from the group consisiting of ERK kinase, S6 kinase, P38 kinase, AbI kinase.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Aug 27, 2009
From: GE BUSINESS FINANCIAL SERVICES INC., FORMERLY MERRILL LYNCH BUSINESS FINANCIAL SERVICES INC.
To: MONOGRAM BIOSCIENCES, INC.
Reel/Frame 023148/0723 →
MERGER Recorded Jun 15, 2009
From: APOLLO ACQUISITION SUB, INC.
To: ACLARA BIOSCIENCES, INC.
Reel/Frame 022824/0503 →
MERGER Recorded Jun 15, 2009
From: ACLARA BIOSCIENCES, INC.
To: APOLLO MERGER SUBSIDIARY, LLC
Reel/Frame 022824/0513 →
MERGER Recorded Jun 15, 2009
From: APOLLO MERGER SUBSIDIARY, LLC
To: VIROLOGIC, INC.
Reel/Frame 022824/0520 →
MERGER Recorded Jun 15, 2009
From: MONOGRAM MERGER SUB, INC.
To: VIROLOGIC, INC.
Reel/Frame 022824/0536 →
SECURITY AGREEMENT Recorded Oct 4, 2006
From: MONOGRAM BIOSCIENCES, INC.
To: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES INC.
Reel/Frame 018338/0818 →